Routine Tests for Hearing Loss in All Cisplatin-Treated Patients
More than half of patients treated with cisplatin-based chemotherapy develop hearing loss or tinnitus, which can be devastating, say researchers who urge that all patients should be tested routinely.
Sonova Research Funding University Of South Florida Autifony Therapeutics Speaker Bureau Otonomy Inc Inst South Florida Hearing Handicap Inventory
Source: medscape.com